Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

Stephanie R. Fink, Stephanie A. Smoley, Sarah F. Paternoster, Kimberly J. Stockero, Lai P. Nguyen, Phuong L. Nguyen, M.D., Curtis A. Hanson, M.D., Gordon W. Dewald, Ph.D.

Blood (2006) 108 (11): 4843.

https://doi.org/10.1182/blood.V108.11.4843.4843

Published: 2006

Journal Articles

Frequency of Clonal Evolution by FISH in Untreated, Early Stage Patients with CLL: A Prospective, Longitudinal Study with Long Clinical Follow-Up.

Tait D. Shanafelt, MD, Stephanie Fink, BS, Tom E. Witzig, MD, Sarah F. Paternoster, Stephanie Smoley, Kim Stockero, Heather C. Flynn, Christine Almer, Robert Jenkins, MD, PhD, Susan Geyer, PhD, Neil E. Kay, MD, Gordy Dewald, PhD

Blood (2005) 106 (11): 2098.

https://doi.org/10.1182/blood.V106.11.2098.2098

Published: 2005

Journal Articles

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Mark Robert Litzow, M.D., Allan B. Dietz, Ph.D., Peggy A. Bulur, Greg W. Butler, Stephanie R. Fink, Louis Letendre, M.D., Sarah F. Paternoster, Ayalew Tefferi, M.D., Antje Hoering, Ph.D., Stanimir Vuk-Pavlovic, Ph.D.

Blood (2004) 104 (11): 2931.

https://doi.org/10.1182/blood.V104.11.2931.2931

Published: 2004

Journal Articles

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Grzegorz S. Nowakowski, MD, Gordon W. Dewald, PhD, Sarah F. Paternoster, Stephanie R. Fink, Stephanie A. Smoley, Ellen D. Remstein, MD, James D. Hoyer, MD, Robert L. Phyliky, MD, Timothy G. Call, MD, Tait D. Shanafelt, MD, Clive S. Zent, MD

Blood (2004) 104 (11): 1919.

https://doi.org/10.1182/blood.V104.11.1919.1919

Published: 2004

Journal Articles

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

Animesh Pardanani, Stephanie R. Brockman, Sarah F. Paternoster, Heather C. Flynn, Rhett P. Ketterling, Terra L. Lasho, Ching-Liang Ho, Chin-Yang Li, Gordon W. Dewald, Ayalew Tefferi

Blood (2004) 104 (10): 3038–3045.

https://doi.org/10.1182/blood-2004-03-0787

Published: 2004

Journal Articles

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Animesh Pardanani, Rhett P. Ketterling, Stephanie R. Brockman, Heather C. Flynn, Sarah F. Paternoster, Brandon M. Shearer, Terra L. Reeder, Chin-Yang Li, Nicholas C. P. Cross, Jan Cools, D. Gary Gilliland, Gordon W. Dewald, Ayalew Tefferi

Blood (2003) 102 (9): 3093–3096.

https://doi.org/10.1182/blood-2003-05-1627

Published: 2003

NARROW

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

Frequency of Clonal Evolution by FISH in Untreated, Early Stage Patients with CLL: A Prospective, Longitudinal Study with Long Clinical Follow-Up.

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Email alerts

ASH Publications

American Society of Hematology

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

Frequency of Clonal Evolution by FISH in Untreated, Early Stage Patients with CLL: A Prospective, Longitudinal Study with Long Clinical Follow-Up.

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only